News

Aclaris Therapeutics to Showcase Innovations at Major Conference

Aclaris Therapeutics to Showcase Innovations at Major Conference

Aclaris Therapeutics to Showcase Innovations at Major Conference

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focusing on groundbreaking treatments for immuno-inflammatory diseases, announced an exciting opportunity to engage with investors and the public. The management team is set to participate in a fireside chat during the highly regarded Piper Sandler 36th Annual Healthcare Conference.

Details of the Conference Participation

This significant event will take place on a specified date in the city known for its dynamic healthcare market, where Aclaris will present its vision and ongoing projects. The members of the Aclaris team look forward to discussing their innovative pipeline aimed at addressing unmet medical needs within the immuno-inflammatory disease space.

Accessing the Webcast

For those interested in tuning into the discussion, a webcast will be available via the "Events" page in the "Investors" section of Aclaris' website. This feature will allow audiences to witness the dialogue and insights shared during the conference, with availability for an extended period post-event.

Understanding Aclaris Therapeutics

At its core, Aclaris Therapeutics is dedicated to crafting novel therapeutic solutions for conditions where existing treatments fall short. The company is proud of its strong research and development capabilities focused on protein kinase regulation, which forms the foundation of its drug candidate portfolio.

Contacting Aclaris Therapeutics

For further inquiries or more detailed information regarding Aclaris Therapeutics' initiatives and innovations, interested parties may contact the company directly. They welcome communication to ensure stakeholders are well-informed about their progress and contributions to the healthcare industry.

Frequently Asked Questions

What is Aclaris Therapeutics known for?

Aclaris Therapeutics is renowned for developing innovative drug candidates for immuno-inflammatory diseases.

When will Aclaris participate in the healthcare conference?

The company will take part in the Piper Sandler Annual Healthcare Conference, with specific timing available on their website.

How can I access the conference webcast?

The webcast will be accessible through the "Events" page in the "Investors" section of Aclaris' website.

What is the focus of Aclaris' research?

Aclaris focuses on addressing unmet needs in immuno-inflammatory diseases, utilizing advanced protein kinase regulation research.

Who can I contact for more information?

For inquiries, you can reach out via the contact email listed on Aclaris Therapeutics’ website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 4

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 9

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 4

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 8

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 1

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading

Top 5 Most Recently Viewed Articles

Jack Henry & Associates Boosts Quarterly Dividend to $.58

Updated Category News Views 98

Jack Henry & Associates Raises Quarterly Dividend Jack Henry & Associates, Inc. (NASDAQ: JKHY) has made a significant announcement regarding its commitment to its shareholders by increasing the quarterly dividend by six percent to $.58 per share. This decision exemplifies the company's dedication to providing value to its stockholders while maintaining a strong financial...

Continue Reading
EXEL Industries Shareholder Update: Voting Rights as of 2025

Updated Category News Views 191

Overview of EXEL Industries EXEL Industries is a renowned French Société Anonyme with a share capital totaling €16,969,750. Located at 54, rue Marcel Paul, 51206 Epernay Cedex, France, the company operates within the framework of the Reims Companies Register (RCS), bearing the number 095 550 356. Current Share and Voting Rights As part of compliance with the...

Continue Reading
ICU Medical Engages in Healthcare Dialogue at Important Conference

Updated Category News Views 120

ICU Medical's Upcoming Participation in a Major Healthcare Conference Exciting developments are on the horizon for ICU Medical, Inc. (Nasdaq: ICUI), a leading innovator in medical technology. The company has announced its participation in an upcoming significant event, the Piper Sandler 37th Annual Healthcare Conference, scheduled in New York City. This event will take...

Continue Reading
Unveil Cherry Blossom Magic at Tokyo Dome Hotel Spring 2025

Updated Category News Views 153

Unveil Cherry Blossom Magic at Tokyo Dome Hotel Spring 2025 Book now and receive up to 50% off during the peak of cherry blossom season Tokyo Dome Hotel, an exquisite venue in the bustling heart of Tokyo, is excited to present a special offer designed for those looking to witness the stunning cherry blossom season. With discounted accommodations of up to 50% off, this...

Continue Reading
Innovative Strategies to Enhance Supply Chain Resilience

Updated Category News Views 101

Enhancing Supply Chain Resilience Through Innovation In today's rapidly changing landscape, Washtenaw Community College (WCC) is set to lead a pivotal discussion on enhancing supply chain resilience. The inaugural Washtenaw Supply Chain Exchange will take place on a notable day, bringing together experts and thought leaders dedicated to navigating the complexities of...

Continue Reading